Your current location: Home >  Industry  >  Culture Tourism  >  health


Loncin adapts to the development trend of the time, grasps opportunity, strengthens layout and develops steadily from pharmaceuticals to human gene medicine and from health service to health care. In 2013, Loncin became a shareholder of Jilin Beisha Pharmaceutical Co., Ltd. which is the world’s fifth largest vitamin E production enterprise. In 2017, the cooperation between Loncin and Shenzhen Huada Gene was intensive, and spring health care project was under planning and implementation. Loncin is steadily promoting strategic planning of big health industry.